The numbers are pretty impressive, more than three dozen new biotech startups now call St. Louis home and collectively they’re hauling in tens of millions of dollars from investors.
Even entrepreneurs who once skipped town for greener pastures are bringing their bio-focused companies back home, and just last week a major piece of a planned $2.1 billion expansion of the life sciences district Cortex fell into place.
As part of St. Louis Public Radio’s series, “A Good Year”, Tim Lloyd spoke with Donn Rubin, president of BioSTL, a regional organization with the aim of turning St. Louis into a haven for bio-tech entrepreneurs, about the swell of bio-tech startups and what it means to the future of the region’s economy.
Follow Tim Lloyd on Twitter: @timslloyd
